You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
亞洲多國疫情惡化 疫苗股普漲
格隆匯 04-22 15:01
格隆匯4月22日丨數據顯示,全球新增確診數連續8週上升,亞洲多國疫情惡化,二級市場上疫苗股持續走強。其中,康希諾AH股今日盤中均漲超10%,安圖生物、萬孚生物、康泰生物等均有不錯漲幅。過去24小時,印度單日新增新冠病例破30萬,續刷全球新高,新增死亡病例2104例。韓國22日新增確診患者人數再次突破700人。比前一天小幅增加,連續兩天超過700人。這也是今年1月7日(869名)以後105天以來的最高紀錄。日本21日新增新冠確診病例5291例,新增死亡病例49例,這是時隔約3個月來,日本單日新增確診病例數再次超過5000例。21日京都府、兵庫縣和東京都請求日本政府宣佈緊急狀態。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account